Cytek Biosciences Inc CTKB
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- $4.62
- Day Range
- $4.52–4.65
- 52-Week Range
- $3.09–6.18
- Bid/Ask
- $3.78 / $4.70
- Shares Outstanding
- 129.14M
- Market Cap
- $591.47M
- Volume/Avg
- 4 / 1M
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 2.89
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- 0.75%
Company Profile
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its patented FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize an inventive method of light detection and distribution to a specifically selected number and type of detectors. Its FSP cell analyzers, the Cytek Aurora, Northern Lights, and Cytek Aurora Evo systems, deliver high-resolution, high-content and high-sensitivity cell analysis and address the inherent limitations of other technologies.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Core
- Total Number of Employees
- 702
- Website
- https://www.cytekbio.com
Valuation
|
Metric
|
CTKB
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 1.82 |
Price/Sales | 2.89 |
Price/Cash Flow | — |
Price/Earnings
CTKB
Financial Strength
|
Metric
|
CTKB
|
|---|---|
Quick Ratio | 3.94 |
Current Ratio | 4.69 |
Interest Coverage | −85.39 |
Quick Ratio
CTKB
Profitability
|
Metric
|
CTKB
|
|---|---|
Return on Assets (Normalized) | −12.59% |
Return on Equity (Normalized) | −16.61% |
Return on Invested Capital (Normalized) | −16.04% |
Return on Assets
CTKB
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|FT%cll | LOCK|k$?V | $175B | |||
| Stryker Corp
SYK
| LOCK|!GqD>L! | LOCK|BCs | $123B | |||
| Medtronic PLC
MDT
| LOCK|J%f!P? | LOCK|$RTf | $106B | |||
| Boston Scientific Corp
BSX
| LOCK|B!bJW^ | LOCK|Mn@b | $65B | |||
| Edwards Lifesciences Corp
EW
| LOCK|?@vv^L$ | LOCK|Krdq | $49B | |||
| DexCom Inc
DXCM
| LOCK|LQsM?B@ | LOCK|#!T@ | $30B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|xgXb#l | LOCK|$M | $29B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|r% | LOCK|<$M | $26B | |||
| Steris PLC
STE
| LOCK|r%D!d&# | LOCK|G$<>? | $21B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|b$gY!#< | LOCK|Fy | $18B |
United States